Digital info vs standard leaflets for advanced sarcoma
Part of Brain & nervous system, Cancer clinical trials.
This trial is testing a digital tool (like videos or online info) to help people with advanced sarcoma understand their treatment better. It compares the digital tool to standard printed leaflets to see which improves understanding and wellbeing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a soft tissue or visceral sarcoma (not bone sarcoma)
- Your sarcoma cannot be removed by surgery (inoperable) and has spread or is locally advanced
- You are about to start treatment with one of these drugs: pazopanib, trabectedin, eribulin, ifosfamide, or dacarbazine
- You are covered by French social security
- You can understand and read French well
- You have access to a computer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether involving a palliative care doctor early during an unplanned hospital stay can improve care for people with advanced cancer. It aims to help patients feel better and have more support during treatment.
This trial tests a combination of chemotherapy, radiation, and two newer drugs (anlotinib and bempegaldesleukin) for people with advanced soft tissue sarcoma that cannot be removed by surgery. The goal is to see if this combination can shrink tumors or slow the cancer's growth.
This study tests whether a digital app or online tool can help you better manage symptoms and side effects from your sarcoma treatment. Researchers want to see if tracking your symptoms online improves how you feel during cancer care.
This study tests whether watching short educational videos helps patients or caregivers of someone with advanced sarcoma that has spread. The trial focuses on people who haven't had any prior treatment for their sarcoma and are comfortable filling out questionnaires in English.
This trial is testing whether a combination of two drugs—a targeted therapy (surufatinib) and an immunotherapy (envafolimab)—can help people with advanced soft tissue sarcoma that has spread or cannot be removed by surgery. Researchers will also use a person's genetic information and scans to see if they can predict who will benefit the most.
This study looks at stored tumor tissue (or takes a new biopsy) to measure specific tumor markers. Researchers want to see whether these markers match how well chemotherapy works before surgery for soft-tissue sarcoma.
Hear when a new Sarcoma Metastatic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.